Merck's $3B AI drug discovery deal, new open-source virtual cell initiative, AI designing full-length antibodies, Europe’s first agentic AI infrastructure for biology & more
Weekly Tech+Bio Highlights #64: Eli Lilly…
Merck's $3B AI drug discovery deal, new open-source virtual cell initiative, AI designing full-length antibodies, Europe’s first agentic AI infrastructure for biology & more